Nature's Sunshine Products price target raised to $20 by DA Davidson

DA Davidson has raised its price target on Nature’s Sunshine Products (NATR) to $20.00, maintaining a Buy rating, citing a "catalyst path to top & bottom line upside" driven by the company's digital-first approach and volume optionality, which are expected to inflect North American growth as soon as Q2 2025 and are currently under-discounted by consensus estimates. The firm highlighted NATR's impressive 71.7% gross profit margins and healthy financial outlook. Concurrently, Fosun Pharma USA, Inc. is conducting a secondary public offering of up to 2.85 million NATR shares, from which Nature’s Sunshine will not receive proceeds but may repurchase up to $15 million, all while the company navigates an impending CEO transition and has reaffirmed its full-year 2025 financial outlook.

Analysis

DA Davidson has upgraded its price target on Nature's Sunshine Products (NATR) to $20.00 from $19.00, reinforcing its Buy rating based on a clear catalyst path for future growth. The firm's optimism is rooted in two key areas currently underappreciated by consensus estimates: the company's digital-first strategy and significant volume optionality. The digital approach is expected to drive a growth inflection in North America as soon as Q2 2025 and is already enhancing margins through sales that do not require volume incentives. This is supported by the company's robust financial health, evidenced by impressive gross profit margins of 71.7%. However, this positive outlook is juxtaposed with two notable events: a secondary public offering of up to 2.85 million shares at $12.00 per share by shareholder Fosun Pharma, and an impending CEO transition. While the offering creates a potential share overhang, Nature's Sunshine may repurchase up to $15 million of the stock, offering a degree of price support. Similarly, management uncertainty is partially mitigated by the company reaffirming its full-year 2025 outlook for net sales and adjusted EBITDA, signaling operational stability.

Key Decisions for Investors

• Investors may view the stock favorably, aligning with DA Davidson's thesis that NATR's digital and volume-based growth catalysts are not fully priced in, suggesting potential for upside beyond current consensus.
• Closely monitor the progress of the CEO succession plan, as a successful leadership transition is critical to executing the growth strategies outlined by the analyst.
• Pay attention to the secondary offering dynamics, as the $12.00 offering price and the company's potential $15 million share repurchase could establish a near-term support level for the stock.